Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia - PubMed (original) (raw)
Review
Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia
Simon W Beaven et al. Annu Rev Med. 2006.
Abstract
Dyslipidemia is the sine qua non of atherosclerosis, but it is also strongly associated with the metabolic syndrome, obesity, diabetes, and fatty liver disease. The molecular basis for future therapies requires understanding the pivotal role of nuclear hormone receptors in lipid and inflammatory homeostasis. This review summarizes evidence that the liver X receptor (LXR) and peroxisome proliferator-activated receptor (PPAR) are key transcriptional regulators in lipid metabolism. Additionally, their effects on glucose homeostasis and inflammation make LXR and PPAR signaling networks attractive molecular targets for managing lipid-related diseases.
Similar articles
- Gaining weight: the Keystone Symposium on PPAR and LXR.
Lehrke M, Pascual G, Glass CK, Lazar MA. Lehrke M, et al. Genes Dev. 2005 Aug 1;19(15):1737-42. doi: 10.1101/gad.1341005. Genes Dev. 2005. PMID: 16077002 Free PMC article. - Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis.
Hansen MK, Connolly TM. Hansen MK, et al. Curr Opin Investig Drugs. 2008 Mar;9(3):247-55. Curr Opin Investig Drugs. 2008. PMID: 18311660 Review. - Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity.
Barish GD. Barish GD. J Nutr. 2006 Mar;136(3):690-4. doi: 10.1093/jn/136.3.690. J Nutr. 2006. PMID: 16484544 Review. - PPARs and LXRs: atherosclerosis goes nuclear.
Barish GD, Evans RM. Barish GD, et al. Trends Endocrinol Metab. 2004 May-Jun;15(4):158-65. doi: 10.1016/j.tem.2004.03.003. Trends Endocrinol Metab. 2004. PMID: 15109614 Review. - Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy.
Tobin JF, Freedman LP. Tobin JF, et al. Trends Endocrinol Metab. 2006 Sep;17(7):284-90. doi: 10.1016/j.tem.2006.07.004. Epub 2006 Jul 25. Trends Endocrinol Metab. 2006. PMID: 16870465 Review.
Cited by
- Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance.
Beaven SW, Matveyenko A, Wroblewski K, Chao L, Wilpitz D, Hsu TW, Lentz J, Drew B, Hevener AL, Tontonoz P. Beaven SW, et al. Cell Metab. 2013 Jul 2;18(1):106-17. doi: 10.1016/j.cmet.2013.04.021. Cell Metab. 2013. PMID: 23823481 Free PMC article. - Liver X receptors, nervous system, and lipid metabolism.
Cermenati G, Brioschi E, Abbiati F, Melcangi RC, Caruso D, Mitro N. Cermenati G, et al. J Endocrinol Invest. 2013 Jun;36(6):435-43. doi: 10.3275/8941. Epub 2013 Apr 18. J Endocrinol Invest. 2013. PMID: 23609963 Review. - The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S, Liu L, Zhuge QC, Yu Z, Zhang X, Xie J, Hong W, Wang S, Yang Y, Chen B. Ding S, et al. Wien Klin Wochenschr. 2012 Oct;124(19-20):671-7. doi: 10.1007/s00508-012-0223-0. Epub 2012 Sep 18. Wien Klin Wochenschr. 2012. PMID: 22987045 Review. - Flavonoids from mulberry leaves inhibit fat production and improve fatty acid distribution in adipose tissue in finishing pigs.
Liu Y, Peng Y, Chen C, Ren H, Zhu J, Deng Y, Cui Q, Hu X, He J, Li H, Zhu X, Yin Y, He J, Xiao Y. Liu Y, et al. Anim Nutr. 2023 Nov 29;16:147-157. doi: 10.1016/j.aninu.2023.11.003. eCollection 2024 Mar. Anim Nutr. 2023. PMID: 38357574 Free PMC article. - Neuronal inactivation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) protects mice from diet-induced obesity and leads to degenerative lesions.
Ma D, Li S, Lucas EK, Cowell RM, Lin JD. Ma D, et al. J Biol Chem. 2010 Dec 10;285(50):39087-95. doi: 10.1074/jbc.M110.151688. Epub 2010 Oct 13. J Biol Chem. 2010. PMID: 20947495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources